Be Biopharma

Cambridge, MA

Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.

be.bio

Twitter
LinkedIn
Crunchbase

Company Details

Founded: 2020
Employees: Between 50 - 200 employees
Raised: $182,000,000
Headquarters Location: Cambridge, MA
Public: No
Acquired: No
CEO: David Steinberg
Founders: David Steinberg
Aleks Radovic-Moreno
Lea Hachigian
David Rawlings
Rich James